KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.

KRTL Holding Group Inc. (OTC: KRTL) today announced the appointment of David Orn as Chief Revenue Officer (CRO) and Rick Haxton as Global Sales Director of its wholly owned subsidiary, KRTL Biotech Inc. These leadership appointments represent a strategic step forward in enhancing KRTL Biotech's revenue generation capabilities and expanding its global market presence.

David Orn, previously an Independent Director of KRTL Holding's Board, transitions into an executive leadership role, bringing decades of experience in healthcare, technology, and strategic development. In his new role as CRO, David will oversee all revenue-generating departments, including sales, business development, and strategic partnerships.

Rick Haxton, newly appointed Global Sales Director, offers extensive expertise in building and leading global sales organizations. His career includes successful track records in domestic and international markets with a focus on regulatory compliance and commercial execution.

"We are extremely pleased to have David and Rick, long-time business partners with a shared history of successful collaboration, bring their combined relationships and complementary expertise to KRTL Biotech. Their established synergy and proven track record position them uniquely to drive the Company's revenue growth and market expansion," said Cesar Herrera, CEO of KRTL Holding Group. "Their leadership experience, industry knowledge, and deep business connections position us to significantly accelerate our revenue growth initiatives and expand market reach. This is a powerful alignment for the future of KRTL Biotech."

As part of their mandate, David and Rick will lead commercialization strategies for KRTL Biotech's pharmaceutical and nutraceutical products, leveraging their networks to build strategic partnerships and drive operational excellence.

"I'm excited to take on this new role and collaborate with Rick to realize the tremendous potential at KRTL Biotech," said David Orn. "Together, we aim to drive sustainable growth and deliver innovative solutions to the market."

"This is an exciting time to join KRTL Biotech," said Rick Haxton. "We are well-positioned to expand our footprint and execute a robust go-to-market strategy that enhances shareholder value."

KRTL Biotech's enhanced leadership team demonstrates the Company's commitment to innovation, strategic execution, and long-term value creation.

About KRTL Holding Group Inc.

KRTL Holding Group Inc. (OTC: KRTL) operates through its wholly owned subsidiaries, KRTL Biotech Inc. and KRTL International Corp. The Company leverages strategic synergies across industries to pursue investments, mergers, and partnerships that deliver shareholder value. Focused on biotech, technology, and emerging market opportunities, KRTL Holding Group is committed to growth, innovation, and operational excellence.

Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as "anticipates," "believes," "plans," "expects," "intends," "projects," "estimates," "future," and "opportunity" and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. These risks and uncertainties include, but are not limited to, changes in regulatory requirements, market conditions, and other factors described in the Company's filings. Additional information concerning risks and uncertainties that could materially affect KRTL’s business and financial results is included in the Company’s filings with the OTC Markets and, where applicable, the SEC. You should not place undue reliance on forward-looking statements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.